You can purchase shares of Edgewise Therapeutics (NASDAQ:EWTX) through any online brokerage.

View our list of the best stock brokerages

Other companies in Edgewise Therapeutics’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Phibro Animal Health Corp (NASDAQ:PAHC), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Terns Pharmaceuticals Inc (NASDAQ:TERN) and Axsome Therapeutics Inc (NASDAQ:AXSM).

Edgewise Therapeutics has a consensus price target of $37.90.

The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $30.84 last updated March 27, 2026 at 4:34 PM EDT.

There are no upcoming dividends for Edgewise Therapeutics.

Edgewise Therapeutics does not have any upcoming earnings scheduled.

There is no upcoming split for Edgewise Therapeutics.

Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.